https://www.selleckchem.com/pr....oducts/n-formyl-met-
The technical success rate of endoleak embolization was 98%. Five patients developed recurrent type 2 endoleaks, while five patients developed a type 1 endoleak. The persistent endoleak rate at a mean initial follow-up of 3 months was 34%. At a mean follow-up of 18 months, 58% of patients demonstrated absence of an endoleak, and 71% showed freedom from AAA sac enlargement. No major adverse events were recorded. The DTA and PG approaches were safe and effective in this cohort of patients undergoing embolization of type
Gefällt mir
Kommentar
Teilen
